Literature DB >> 24687020

Circulating CD1c(+) DCs are superior at activating Th2 responses upon Phl p stimulation compared with basophils and pDCs.

Frida Rydnert1, Kristina Lundberg1, Lennart Greiff2, Malin Lindstedt1.   

Abstract

The contributing role of circulating human dendritic cell (DC) populations and basophils in the presentation and augmentation of Th2 responses remains to be determined. The present study aimed at elucidating the functional role of CD1c(+) myeloid DCs (mDCs), CD123(+) plasmacytoid DCs (pDCs), monocyte-derived DCs and basophils in allergen presentation and Th2 activation. By coculturing Phleum pratense (Phl p)-pulsed CD1c(+) mDCs, CD123(+) pDCs, monocyte-derived DCs and basophils with autologous CD4(+) effector memory T cells, we assessed T-cell proliferation as well as the frequency of interleukin-4- and interferon-γ-producing T cells. Interestingly, a Th2-stimulating ability was observed for Phl p-challenged CD1c(+) mDCs and monocyte-derived DCs, while CD123(+) pDCs and basophils did not affect the Th-balance. In addition, both Phl p-pulsed CD1c(+) mDCs and monocyte-derived DCs stimulated increased T-cell proliferation compared to basophils and CD123(+) pDCs. Together, these results point to a prominent role for circulating CD1c(+) mDCs in allergen presentation and augmentation of Th2 responses, making them promising therapeutic targets for Type I hypersensitivity reactions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24687020     DOI: 10.1038/icb.2014.23

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  2 in total

Review 1.  Human dendritic cell subsets and function in health and disease.

Authors:  Meredith O'Keeffe; Wai Hong Mok; Kristen J Radford
Journal:  Cell Mol Life Sci       Date:  2015-08-05       Impact factor: 9.261

2.  Allergen-Specific Immunotherapy Alters the Frequency, as well as the FcR and CLR Expression Profiles of Human Dendritic Cell Subsets.

Authors:  Kristina Lundberg; Frida Rydnert; Sissela Broos; Morgan Andersson; Lennart Greiff; Malin Lindstedt
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.